Life sciences firms are moving beyond traditional industry boundaries to create new health care solutions for patients and providers. Recent scientific advances and improvements in enabling technologies have opened new avenues for convergence among drugs, diagnostics and devices. Aging populations and rising consumerism are increasing demand for health care products that offer greater effectiveness and convenience. These shifting industry and market conditions are creating both pressures and new opportunities for life sciences companies. Explore the links below to learn more about the move toward convergence. Related Content:
Interview: Life Sciences Industry - Converging for Better Care
Overview: Catch the Life Sciences Wave
Overview: Life Sciences & Health Care in Emerging Markets
Services: Life Sciences Stay Connected: Subscriptions Sign up to receive the latest insights and ideas from the Deloitte Life Sciences industry practice and the Deloitte Center for Health Solutions. Receive e-alerts when new research, Dbriefs Webcasts and podcasts are available (free; registration required). Subscribe to receive e-mail notifications. As used in this document, ‘Deloitte’ means Deloitte LLP (and its subsidiaries). Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.
|